Dr. Helen Ma, MD
Claim this profileTibor Rubin VA Medical Center
Studies Lymphoma
Studies Peripheral T-Cell Lymphoma
4 reported clinical trials
19 drugs studied
Area of expertise
1Lymphoma
13q positive
13q negative
12 positive
2Peripheral T-Cell Lymphoma
Affiliated Hospitals
Clinical Trials Helen Ma, MD is currently running
Azacytidine + Romidepsin
for Peripheral T-Cell Lymphoma
This trial is testing if a combination of two drugs, romidepsin and azacytidine, is safe and effective for patients with aggressive Peripheral T-Cell Lymphoma that hasn't responded to other treatments. The goal is to see if this combination works better than using just one drug alone. Romidepsin is approved for certain types of T-cell lymphoma and has shown positive results in various T-cell cancers.
Recruiting1 award Phase 211 criteria
Screening Tool
for Myeloid Cancer
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates the use of a screening tool and specific laboratory tests to help improve participants' ability to register to clinical trials throughout the course of their myeloid cancer (acute myeloid leukemia or myelodysplastic syndrome) treatment. This study involves testing patients' bone marrow and blood for certain biomarkers. A biomarker (sometimes called a marker) is any molecule in the body that can be measured. Doctors look at markers to learn what is happening in the body. Knowing about certain markers can give doctors more information about what is driving the cancer and how to treat it. Testing patients' bone marrow and blood will show doctors if patients have markers that specific drugs can target. The marker testing in this study will let doctors know if they can match patients with a treatment study (myeloMATCH clinical trial) that tests treatment for the type of cancer they have or continue standard of care treatment with their doctor on the Tier Advancement Pathway (TAP).
Recruiting0 awards Phase 21 criteria
More about Helen Ma, MD
Clinical Trial Related4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Helen Ma, MD has experience with
- Venetoclax
- Azacytidine
- Romidepsin
- Obinutuzumab
- Cyclophosphamide
- Oral Azacitidine
Breakdown of trials Helen Ma, MD has run
Lymphoma
Peripheral T-Cell Lymphoma
Chronic Lymphocytic Leukemia
Diffuse Large B-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Helen Ma, MD specialize in?
Helen Ma, MD focuses on Lymphoma and Peripheral T-Cell Lymphoma. In particular, much of their work with Lymphoma has involved 13q positive patients, or patients who are 13q negative.
Is Helen Ma, MD currently recruiting for clinical trials?
Yes, Helen Ma, MD is currently recruiting for 3 clinical trials in Long Beach California. If you're interested in participating, you should apply.
Are there any treatments that Helen Ma, MD has studied deeply?
Yes, Helen Ma, MD has studied treatments such as Venetoclax, Azacytidine, Romidepsin.
What is the best way to schedule an appointment with Helen Ma, MD?
Apply for one of the trials that Helen Ma, MD is conducting.
What is the office address of Helen Ma, MD?
The office of Helen Ma, MD is located at: Tibor Rubin VA Medical Center, Long Beach, California 90822 United States. This is the address for their practice at the Tibor Rubin VA Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.